(Q48959687)

17 February 2018

title

Early induction of interleukin-6 mRNA in the hippocampus and cortex of APPsw transgenic mice Tg2576. (English)

1 reference

17 February 2018

author

Marianne Schultzberg

5

1 reference

17 February 2018

author name string

Tehranian R

1

1 reference

17 February 2018

Hasanvan H

2

1 reference

17 February 2018

Iverfeldt K

3

1 reference

17 February 2018

Post C

4

1 reference

17 February 2018

language of work or name

English

0 references

publication date

1 March 2001

1 reference

17 February 2018

number of pages

5

1 reference

inferred from page(s)

published in

Neuroscience Letters

1 reference

17 February 2018

volume

301

1 reference

17 February 2018

issue

1

1 reference

17 February 2018

page(s)

54-58

1 reference

17 February 2018

Inflammation and Alzheimer's disease

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2801%2901592-0

7 January 2021

Interleukin-6 and α-2-macroglobulin indicate an acute-phase state in Alzheimer's disease cortices

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2801%2901592-0

7 January 2021

Evidence for glial-mediated inflammation in aged APP(SW) transgenic mice

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2801%2901592-0

7 January 2021

Interleukin-1 beta and interleukin-6 are elevated in the cerebrospinal fluid of Alzheimer's and de novo Parkinson's disease patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2801%2901592-0

7 January 2021

Neurologic disease induced in transgenic mice by cerebral overexpression of interleukin 6

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2801%2901592-0

7 January 2021

Expression of ced-3 and ced-9 homologs in Alzheimer's disease cerebral cortex.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2801%2901592-0

7 January 2021

Age-associated increased interleukin-6 gene expression, late-life diseases, and frailty

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2801%2901592-0

7 January 2021

Induction of tumor necrosis factor-alpha mRNA in the brain after peripheral endotoxin treatment: comparison with interleukin-1 family and interleukin-6.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2801%2901592-0

7 January 2021

Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2801%2901592-0

7 January 2021

Brain interleukin 1 and S-100 immunoreactivity are elevated in Down syndrome and Alzheimer disease

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2801%2901592-0

7 January 2021

Transgenic mice expressing Alzheimer amyloid precursor proteins.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2801%2901592-0

7 January 2021

Correlative Memory Deficits, Abeta Elevation, and Amyloid Plaques in Transgenic Mice

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2801%2901592-0

7 January 2021

Anti-inflammatory drugs and Alzheimer disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2801%2901592-0

7 January 2021

Induction of cytokines in glial cells surrounding cortical beta-amyloid plaques in transgenic Tg2576 mice with Alzheimer pathology

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2801%2901592-0

7 January 2021

A pathogenic mutation for probable Alzheimer's disease in the APP gene at the N-terminus of beta-amyloid

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2801%2901592-0

7 January 2021

Interleukin-6 (IL-6) and soluble forms of IL-6 receptors are not altered in cerebrospinal fluid of Alzheimer's disease patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2801%2901592-0

7 January 2021

A genetic variation of the inflammatory cytokine interleukin-6 delays the initial onset and reduces the risk for sporadic Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2801%2901592-0

7 January 2021

Clinical trial of indomethacin in Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2801%2901592-0

7 January 2021

Cloning of a gene bearing missense mutations in early-onset familial Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2801%2901592-0

7 January 2021

Regionally specific induction of ICE mRNA and enzyme activity in the rat brain and adrenal gland by LPS.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2801%2901592-0

7 January 2021

Decreased interleukin-6 level in the cerebrospinal fluid of patients with Alzheimer-type dementia

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2801%2901592-0

7 January 2021

Increased interleukin-1beta converting enzyme expression and activity in Alzheimer disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2801%2901592-0

7 January 2021

10.1016/S0304-3940(01)01592-0

Identifiers

DOI

1 reference

17 February 2018

PubMed ID

11239715

1 reference

17 February 2018